livemint.com
78%
892
Oxford Covid-19 vaccine: Serum Institute begins last phase of clinical trial
Covid-19 vaccine 'Covishield', being developed by Oxford University, and manufactured by the Serum Institute of India (SII), began today at the state-run Sassoon General Hospital here in Maharashtra on Monday, a senior official said."We have started the phase-III trials of the vaccine candidate.